83 related articles for article (PubMed ID: 4473796)
1. Proceedings: Amine precursors in depression: studies combining L-DOPA and L-tryptophan.
Dunner DL
Psychopharmacol Bull; 1974 Oct; 10(4):56-7. PubMed ID: 4473796
[No Abstract] [Full Text] [Related]
2. Affective disorder: studies with amine precursors.
Dunner DL; Fieve RR
Am J Psychiatry; 1975 Feb; 132(2):180-3. PubMed ID: 1089363
[TBL] [Abstract][Full Text] [Related]
3. Treatment of depression by altering monoamine metabolism: precursors and metabolic inhibitors.
Baldessarini RJ
Psychopharmacol Bull; 1984; 20(2):224-39. PubMed ID: 6728992
[No Abstract] [Full Text] [Related]
4. New antidepressant drugs: a clinical perspective.
Gelenberg AJ
Psychopharmacol Bull; 1984; 20(2):291-4. PubMed ID: 6728993
[No Abstract] [Full Text] [Related]
5. Use of L-DOPA in depression.
Frazer A; Mendels J
Adv Biochem Psychopharmacol; 1977; 16():671-5. PubMed ID: 329654
[No Abstract] [Full Text] [Related]
6. Amine precursors and depression.
Mendels J; Stinnett JL; Burns D; Frazer A
Arch Gen Psychiatry; 1975 Jan; 32(1):22-30. PubMed ID: 1089400
[TBL] [Abstract][Full Text] [Related]
7. Use of neurotransmitter precursors for treatment of depression.
Meyers S
Altern Med Rev; 2000 Feb; 5(1):64-71. PubMed ID: 10696120
[TBL] [Abstract][Full Text] [Related]
8. L-tryptophan in the treatment of levodopa induced psychiatric disorders.
Miller EM; Nieburg HA
Dis Nerv Syst; 1974 Jan; 35(1):20-3. PubMed ID: 17894051
[TBL] [Abstract][Full Text] [Related]
9. Amine precursors, amines, and false neurotransmitters in depressed patients.
Murphy DL
Am J Psychiatry; 1972 Aug; 129(2):141-8. PubMed ID: 4339314
[No Abstract] [Full Text] [Related]
10. L-tryptophan and depressive illness.
Drug Ther Bull; 1972 Sep; 10(19):75-6. PubMed ID: 5078540
[No Abstract] [Full Text] [Related]
11. Theoretical and therapeutic potential of indolamine precursors in affective disorders.
Wirz-Justice A
Neuropsychobiology; 1977; 3(4):199-233. PubMed ID: 304193
[TBL] [Abstract][Full Text] [Related]
12. [Tryptophan metabolism during depression].
Mangoni A
Riv Sper Freniatr Med Leg Alien Ment; 1968 Aug; 92(4):1109-18. PubMed ID: 5738061
[No Abstract] [Full Text] [Related]
13. Theoretical and therapeutic potential of indoleamine precursors (2).
Wirz-Justice A
Nihon Rinsho; 1976 Oct; 34(10):3049-51. PubMed ID: 1034043
[No Abstract] [Full Text] [Related]
14. Studies in the mechanism of action of serotonin precursors in depression.
van Praag HM
Psychopharmacol Bull; 1984; 20(3):599-602. PubMed ID: 6473668
[No Abstract] [Full Text] [Related]
15. Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa.
Rodgers KJ; Hume PM; Morris JG; Dean RT
J Neurochem; 2006 Aug; 98(4):1061-7. PubMed ID: 16771833
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease.
Kostrzewa RM; Kostrzewa JP; Brus R
Amino Acids; 2002; 23(1-3):57-63. PubMed ID: 12373519
[TBL] [Abstract][Full Text] [Related]
17. Letter: Tryptophan plus a pyrrolase inhibitor for depression?
Fernando JC; Joseph MH; Curzon G
Lancet; 1975 Jan; 1(7899):171. PubMed ID: 46093
[No Abstract] [Full Text] [Related]
18. [Central serotonin metabolism in depression].
van Praag HM
Ned Tijdschr Geneeskd; 1980 Jun; 124(24):964-71. PubMed ID: 6966766
[No Abstract] [Full Text] [Related]
19. [Biochemical depression].
Jovicić A; Nikić S; Marković M
Med Pregl; 1980; 33(1-2):55-7. PubMed ID: 7412726
[No Abstract] [Full Text] [Related]
20. [Antidepressant effect of L-tryptophan in male rats with dysbalance thyreoid hormones].
Masalova OO; Sapronov NS
Eksp Klin Farmakol; 2005; 68(3):7-9. PubMed ID: 16047670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
